Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy | Zendy

Mika Hilvo | Zendy; Lars Wallentin | Zendy; Tatevik Ghukasyan Lakic | Zendy; Claes Held | Zendy; Dimple Kauhanen | Zendy; Antti Jylhä | Zendy; Johan Lindbäck | Zendy; Agneta Siegbahn | Zendy; Christopher B. Granger | Zendy; Wolfgang Köenig | Zendy; Ralph Stewart | Zendy; Harvey D. White | Zendy; Reijo Laaksonen | Zendy; the STABILITY Investigators | Zendy

Open Access

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Author(s) -

Mika Hilvo,

Lars Wallentin,

Tatevik Ghukasyan Lakic,

Claes Held,

Dimple Kauhanen,

Antti Jylhä,

Johan Lindbäck,

Agneta Siegbahn,

Christopher B. Granger,

Wolfgang Köenig,

Ralph Stewart,

Harvey D. White,

Reijo Laaksonen,

the STABILITY Investigators

Publication year - 2020

Publication title -

journal of the american heart association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.494

H-Index - 85

ISSN - 2047-9980

DOI - 10.1161/jaha.119.015258

Subject(s) - medicine , heart failure , myocardial infarction , cardiology , framingham risk score , hazard ratio , copeptin , clinical endpoint , stroke (engine) , placebo , disease , randomized controlled trial , confidence interval , pathology , vasopressin , mechanical engineering , engineering , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog